Enovis Corporation ENOV
Analyst Ratings
- Consensus
- Buy — 10 Buy · 0 Hold · 0 Sell (10 analysts)
- Avg. Price Target
- $39.44 (+42.5% upside)
Key Stats
- Today's Range
- $27.63 – $28.89
- 50-Day Range
- $16.70 – $29.89
- 52-Week Range
- $16.70 – $34.28
- Volume
- 1.21 million shs
- Average Volume
- 1.69 million shs
- Market Cap
- $1.60 billion
- P/E Ratio
- —
- Dividend Yield
- —
Short Interest
- Short Interest
- 3.86%
- Days to Cover
- 2.17
About Enovis Corporation
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
Related Stocks
Compare head-to-head: ENOV vs STE·ENOV vs ZBH·ENOV vs MSA·ENOV vs SMTI
Price and fundamental data are delayed and provided for informational purposes only. Not investment advice. See our disclaimer.